ReviewMDM policy & practice
Discussing Cost and Value in Patient Decision Aids and Shared Decision Making: A Call to Action.
Review in MDM policy & practice. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed.
- The impact of adding cost information to a conversation aid to support shared decision making about low-risk prostate cancer treatment: Results of a stepped-wedge cluster randomised trial.Health expectations : an international journal of public participation in health care and health policy · 2023Trial
- Advanced cancer treatment decisions and their patient-facing financial burdens: a thematic analysis.The oncologist · 2026Article
- Patient decision aid-supported shared decision making and short-term decision-making outcomes in type 2 diabetes: a prospective observational comparative study.BMC medical informatics and decision making · 2026Observational
- Economic information in clinical decision-making: focus group discussions with Finnish general practitioners and patients.BMJ open · 2026Article
- Evaluation of a large language model for clinician-facing preoperative cost-communication preparation in total knee arthroplasty.Frontiers in medicine · 2026Article
- Patient Perspectives on Health Insurance Design: A Mixed-Methods Analysis.Journal of market access & health policy · 2025Article
- Willingness to pay for assisted reproductive technologies among individuals with infertility in China.Health policy and planning · 2025Article
- Factors influencing patients to choose one obesity treatment over another: a qualitative study.International journal of obesity (2005) · 2025Article
- Patients' Attitudes Towards Integrating Environmental Sustainability Into Healthcare Decision-Making: An Interview Study.Health expectations : an international journal of public participation in health care and health policy · 2025Article
- Costs of non-metastatic prostate cancer treatment among privately insured men in the United States.PloS one · 2025Article
- Development of a decision aid with cost information for heart failure medication in Singapore.PEC innovation · 2024Article
- How to Use Costs in Value-Based Healthcare: Learning from Real-life Examples.Journal of general internal medicine · 2024Article
- "You Have to Rob Peter to Pay Paul So Your Kid Can Breathe": Using Qualitative Methods to Characterize Trade-Offs and Economic Impact of Asthma Care Costs.Medical care · 2023Article
- US practice adoption of patient-engagement strategies and spending for adults with diabetes and cardiovascular disease.Health affairs scholar · 2023Article
- Financial burden of men with localized prostate cancer: a process paper.Frontiers in psychology · 2023Article
- Financial Toxicity Considerations in Breast Reconstruction: Recommendations for Research and Practice.Women's health issues : official publication of the Jacobs Institute of Women's HealthArticle
- "I Just Had to Do What I Had to Do": Characterizing Direct and Indirect Prostate Cancer Treatment Costs for Black Survivors and Their Caregivers.MDM policy & practiceArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Direct and indirect costs of care influence patients' health choices and the ability to implement those choices. Despite the significant impact of care costs on patients' health and daily lives, patient decision aid (PtDA) and shared decision-making (SDM) guidelines almost never mention a discussion of costs of treatment options as part of minimum standards or quality criteria. Given the growing study of the impact of costs in health decisions and the rising costs of care more broadly, in fall 2021 we organized a symposium at the Society for Medical Decision Making's annual meeting. The focus was on the role of cost information in PtDAs and SDM. Panelists gave an overview of work in this space at this virtual meeting, and attendees engaged in rich discussion with the panelists about the state of the problem as well as ideas and challenges in incorporating cost-related issues into routine care. This article summarizes and extends our discussion based on the literature in this area and calls for action. We recommend that PtDA and SDM guidelines routinely include a discussion of direct and indirect care costs and that researchers measure the frequency, quality, and response to this information.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.